During the past decade, Bogna Gabrylewicz Andrzej Ochala Unimed s.c. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bogna Gabrylewicz Andrzej Ochala Unimed s.c." are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Bogna Gabrylewicz Andrzej Ochala Unimed s.c." in a lesser frequency.

Most popular intervention types in "Bogna Gabrylewicz Andrzej Ochala Unimed s.c." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bogna Gabrylewicz Andrzej Ochala Unimed s.c." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Bogna Gabrylewicz Andrzej Ochala Unimed s.c.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Bogna Gabrylewicz Andrzej Ochala Unimed s.c., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Bogna Gabrylewicz Andrzej Ochala Unimed s.c., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".